![]() |
市場調查報告書
商品編碼
2085930
醫療設備安全市場:2026-2032年全球市場預測(依設備類型、組件、連接方式、安全類型、部署模式和最終用戶分類)Medical Device Security Market by Device Type, Component, Connectivity, Security Type, Deployment Mode, End User - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,醫療設備安全市場將成長至 225.4 億美元,複合年成長率為 12.69%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 97.6億美元 |
| 預計年份:2026年 | 109億美元 |
| 預測年份 2032 | 225.4億美元 |
| 複合年成長率 (%) | 12.69% |
隨著連網醫療設備、醫療設備、遠端患者監護平台和醫院物聯網系統的普及,臨床攻擊面不斷擴大,醫療設備安全已成為經營團隊的首要任務。日益嚴格的監管要求、針對醫療機構的日益複雜的勒索軟體攻擊,以及保護病患安全、敏感健康資訊和臨床系統正常運作的營運需求,共同塑造了這一市場運作。
政策發展方向明確。根據《聯邦食品、藥品和化妝品法案》(FD&C Act)第524B條,美國FDA要求許多新的醫療設備申請提交網路安全訊息,包括安全開發實踐、漏洞管理和軟體材料清單(SBOM)的要求。在全球範圍內,來自NIST、IMDRF、IEC 81001-5-1和歐盟醫療設備法規(MDR)的框架正在加強「安全設計」原則在醫療設備整個生命週期中的應用。
醫療設備的安全格局正從基於邊界的防護轉向貫穿整個生命週期的網路風險管理。醫療服務提供者和製造商正朝著資產識別、網路分段、基於身分的存取控制、持續監控、協調漏洞揭露以及上市後監控等方向發展,這些措施將涵蓋互聯設備的整個運作。
人工智慧 (AI) 透過改善資產分類、異常檢測、漏洞優先排序、惡意軟體分析、詐欺偵測和保全行動工作流程,對醫療設備的整體安全性產生了累積影響。與僅靠人工檢查相比,AI 驅動的監控能夠更快地識別異常設備行為、可疑網路流量和入侵的早期徵兆。這在高度重要的臨床環境中至關重要。
在亞太地區,隨著數位醫療基礎設施、互聯診斷和醫院現代化進程的推進,中國、日本、韓國、印度、澳洲和東協等市場正經歷快速發展。該地區的需求成長主要得益於數位醫療的進步、患者數量的增加以及國家層面網路安全政策的加強,但在採購標準、醫院安全響應能力以及醫療設備網路安全要求的本地化實施方面,各地區之間存在成熟度差異。
隨著新加坡、馬來西亞、泰國、印尼、越南和菲律賓不斷拓展其數位醫療計畫和互聯醫療服務,東協正成為重要的成長區域。該地區的安全措施最為先進,各國網路安全機構、醫院認證計畫、資料保護法規和雲端醫療平台都更為成熟。新加坡在醫療保健領域的網路安全準備方面,往往為該地區樹立了高標準。
美國在監管清晰度和商業性需求方面處於主導地位,這得益於FDA的網路安全預期、HHS的指導意見、HIPAA的安全要求、CISA針對醫療保健行業的諮詢,以及醫療保健行業面臨的高網路風險。加拿大則專注於隱私保護、公共醫療保健的韌性以及醫療技術的現代化,而墨西哥和巴西則透過私立醫院的成長、遠端醫療診斷和遠距醫療的普及以及醫療保健資料管治的加強來拓展商機。
產業領導者應將醫療設備安全視為企業風險管理職能,而非狹義的IT管理職能。製造商應根據FDA、NIST、IMDRF和IEC 81001-5-1的要求,實施「安全設計」、威脅建模、安全物料清單(SBOM)管治、協調漏洞揭露、安全更新機制、加密保護和上市後監測等措施。
本執行摘要採用系統化的二手調查方法編寫,重點關注檢驗、公開且權威的資訊來源。分析內容涵蓋了美國食品藥物管理局 (FDA)、美國國家標準與技術研究院 (NIST)、美國網路安全與基礎設施安全局 (CISA)、美國衛生與公眾服務部 (HHS)、國際醫療器材風險論壇 (IMDRF)、歐盟委員會、歐洲網路與安全局 (ENISA) 以及經認可的網路發展機構的監管建議,以及關於醫療設備的監管
醫療設備安全正朝著更規範、監管更嚴格、情報主導的方向發展。互聯醫療、人工智慧醫療技術、日益嚴格的網路安全要求以及醫療保健領域持續存在的網路威脅,都促使人們對產品設計、部署、營運和售後支援等各環節的安全期望不斷提高。
The Medical Device Security Market is projected to grow by USD 22.54 billion at a CAGR of 12.69% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 9.76 billion |
| Estimated Year [2026] | USD 10.90 billion |
| Forecast Year [2032] | USD 22.54 billion |
| CAGR (%) | 12.69% |
Medical device security has become a board-level priority as connected medical devices, software as a medical device, remote patient monitoring platforms, and hospital IoT systems expand the clinical attack surface. The market is being shaped by stricter regulatory expectations, more sophisticated ransomware activity targeting healthcare delivery organizations, and the operational need to protect patient safety, protected health information, and clinical uptime.
Verified policy momentum is clear. The U.S. FDA requires cybersecurity information for many new device submissions under Section 524B of the FD&C Act, including secure development practices, vulnerability management, and software bill of materials expectations. Globally, frameworks from NIST, IMDRF, IEC 81001-5-1, and the EU Medical Device Regulation are reinforcing secure-by-design principles across the medical device lifecycle.
The medical device security landscape is shifting from perimeter-based protection to lifecycle cyber risk management. Healthcare providers and manufacturers are moving toward asset discovery, network segmentation, identity-based access, continuous monitoring, coordinated vulnerability disclosure, and postmarket surveillance that extends across the full operating life of connected devices.
Regulatory and procurement practices are also changing. Buyers increasingly expect evidence of threat modeling, secure software development, SBOM availability, patching processes, encryption, authentication controls, and incident response readiness. As legacy devices remain in service for years, security programs must balance patient safety, device availability, regulatory compliance, and modernization without disrupting clinical workflows.
Artificial intelligence is creating cumulative impact across medical device security by improving asset classification, anomaly detection, vulnerability prioritization, malware analysis, fraud detection, and security operations workflows. AI-enabled monitoring can help identify abnormal device behavior, suspicious network traffic, and early indicators of compromise faster than manual review alone, which is critical in high-acuity clinical environments.
AI also introduces new risk considerations. Connected devices using machine learning may face model manipulation, data poisoning, adversarial inputs, privacy exposure, and validation challenges. Industry leaders are therefore aligning AI governance with FDA guidance on software, NIST AI Risk Management Framework principles, secure MLOps, auditability, and human oversight to ensure that AI strengthens resilience without creating unmanaged clinical or cybersecurity risk.
Asia-Pacific is advancing rapidly as China, Japan, South Korea, India, Australia, and ASEAN markets scale digital health infrastructure, connected diagnostics, and hospital modernization. The region's demand is driven by growing healthcare digitization, larger patient populations, and stronger national cybersecurity policies, although maturity varies across procurement standards, hospital security capacity, and local implementation of medical device cybersecurity requirements.
North America remains a leading region due to FDA cybersecurity requirements, mature healthcare IT investment, high ransomware exposure, HIPAA-aligned security programs, and strong adoption of connected medical technologies. Europe is shaped by the EU MDR, NIS2 Directive, GDPR, ENISA guidance, and rising attention to cyber resilience, while Latin America is moving gradually as Brazil and Mexico expand digital care delivery, private hospital networks, and health data protection frameworks. The Middle East is investing in smart hospitals and national health transformation programs, particularly across the GCC, while Africa shows emerging demand tied to telemedicine, public health infrastructure modernization, donor-supported digital health initiatives, and the need for scalable, cost-effective security controls.
ASEAN is becoming an important growth zone as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand digital health programs and connected care delivery. Security adoption is strongest where national cybersecurity agencies, hospital accreditation programs, data protection rules, and cloud health platforms are more mature, with Singapore often setting a higher regional benchmark for healthcare cyber readiness.
The GCC is accelerating medical device security through smart hospital investments, public-sector healthcare transformation, and cloud-first strategies in Saudi Arabia, the UAE, Qatar, and neighboring markets. The European Union is one of the most regulation-driven environments, with MDR, GDPR, NIS2, and cyber resilience initiatives pushing manufacturers and providers toward documented security controls. BRICS countries combine scale and complexity, with China and India driving high-volume connected healthcare demand and Brazil and South Africa expanding digital health capacity. G7 and NATO members emphasize supply-chain assurance, vulnerability disclosure, critical infrastructure protection, ransomware resilience, and preparedness against state-linked cyber threats that can affect healthcare delivery and medical technology operations.
The United States leads in regulatory clarity and commercial demand, supported by FDA cybersecurity expectations, HHS guidance, HIPAA security requirements, CISA healthcare advisories, and high healthcare cyber risk exposure. Canada emphasizes privacy, public healthcare resilience, and medical technology modernization, while Mexico and Brazil are expanding opportunities through private hospital growth, connected diagnostics, telehealth adoption, and stronger health data governance.
In Europe, the United Kingdom, Germany, France, Italy, and Spain are strengthening hospital cybersecurity programs under national strategies, EU-aligned requirements, data protection obligations, and growing awareness of medical device vulnerabilities. Russia remains a distinct market shaped by local regulatory priorities, cybersecurity sovereignty policies, and import substitution pressures. In Asia-Pacific, China and India offer large-scale demand as healthcare digitization accelerates, while Japan, South Korea, and Australia show stronger security maturity through advanced hospital systems, medical technology manufacturing, national cybersecurity frameworks, and established digital health infrastructure.
Industry leaders should treat medical device security as an enterprise risk function rather than a narrow IT control. Manufacturers should implement secure-by-design engineering, threat modeling, SBOM governance, coordinated vulnerability disclosure, secure update mechanisms, cryptographic protections, and postmarket monitoring aligned with FDA, NIST, IMDRF, and IEC 81001-5-1 expectations.
Healthcare providers should build accurate device inventories, segment clinical networks, enforce identity and access controls, monitor device behavior, test incident response plans, and prioritize remediation based on clinical risk and patient safety impact. Both manufacturers and providers should strengthen third-party risk management, require cybersecurity evidence in procurement, and create cross-functional governance involving clinical engineering, IT security, compliance, legal, procurement, and patient safety teams.
This executive summary is developed using a structured secondary-research methodology focused on verified, publicly available, and authoritative sources. The analysis reflects regulatory publications from the FDA, NIST, CISA, HHS, IMDRF, the European Commission, ENISA, and recognized standards bodies, alongside healthcare cybersecurity advisories, medical device guidance, and market-relevant policy developments.
The methodology emphasizes triangulation across regulatory signals, technology adoption patterns, regional healthcare digitization trends, cybersecurity threat intelligence, privacy requirements, and procurement expectations. Insights are synthesized to identify durable market drivers, risk factors, regional differences, and strategic implications for manufacturers, healthcare providers, investors, and cybersecurity vendors serving the medical device ecosystem.
Medical device security is entering a more disciplined, regulated, and intelligence-driven phase. The convergence of connected care, AI-enabled medical technologies, stricter cybersecurity requirements, and persistent healthcare cyber threats is raising expectations for security across product design, deployment, operations, and postmarket support.
Organizations that invest in secure-by-design devices, continuous monitoring, AI-assisted risk management, transparent software supply chains, and coordinated vulnerability response will be better positioned to protect patient safety, maintain clinical continuity, and meet evolving global compliance requirements. Medical device security is no longer optional; it is a foundational requirement for trusted digital healthcare.